Researchers Use Nanoparticles to Test Treatment for Liver Disease

June 25, 2018 | Katie Neith

In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.

Continue Reading

Really Big Data: How Genomics Is Poised to Reshape Cancer Care

November 9, 2017 | Abe Rosenberg

The exploding field of cancer genomics is enabling that kind of prediction for a growing number of inherited cancers, like identifying one of the many genes beyond BRCA1 and BRCA2 gene mutations linked to breast cancer.

Survey: Physicians need more training about cancer gene tests

June 12, 2013 | Nicole White

The discovery of genes that may increase a woman’s risk of developing breast cancer has resulted in potentially powerful tools to guide care – but like all new technologies, there’s a learning curve. Although physicians are comfortable ordering single-gene tests, they are hesitant to order the latest multigene panels for cancer risk assessment without additional training in using and interpreting the results, a survey found.

BRCA-related choices depend on quality genetic tests, counseling

May 24, 2013 | Tami Dennis

Angelina Jolie’s decision to have prophylactic mastectomies has fueled much discussion over the plight of women who learn they have genetic mutations linked to breast and ovarian cancer. But sometimes, as a recent story points out, the decision is based on faulty information.

5 myths, and the reality, about genetic testing for breast cancer

April 12, 2013 | Wayne Lewis

People with a family history of breast cancer often seek genetic testing to find out whether they carry mutations to key genes called BRCA1 and BRCA2, greatly increasing their risk for breast cancer and other diseases.